[Arrhythmia]

Area of Science:

• Cardiology
• Electrophysiology
• Medical Technology

Background:

• Atrial fibrillation (AF) management involves stroke prevention, rate/rhythm control, and non-pharmacological therapies.
• Current treatment guidelines emphasize a comprehensive approach to AF care.
• Non-pharmacological treatments, particularly catheter ablation, are increasingly vital for improving patient outcomes.

Purpose of the Study:

• To review current treatment principles for atrial fibrillation (AF).
• To highlight advancements in non-pharmacological AF therapies, including catheter ablation and surgical techniques.
• To discuss the evolving landscape and future directions in AF management.

Main Methods:

• Review of current atrial fibrillation (AF) treatment guidelines and emerging therapeutic modalities.
• Analysis of technological advancements in catheter ablation (radiofrequency, balloon, pulsed-field) and surgical procedures (robotic, thoracoscopic, minimally invasive).
• Discussion of evolving indications and strategies for AF ablation, particularly for persistent AF.

Main Results:

• Catheter ablation has evolved significantly, with new technologies like pulsed-field ablation promising minimal complications.
• Surgical interventions are becoming less invasive, including robotic and thoracoscopic approaches.
• Ablation strategies for paroxysmal AF are established, while persistent AF management is a growing focus.

Conclusions:

• Non-pharmacological treatments, especially catheter ablation and minimally invasive surgery, are crucial for improving AF patient outcomes.
• Ongoing technological advancements are enhancing the safety and efficacy of AF interventions.
• Future research should focus on integrated heart team approaches and optimized treatment systems for complex AF cases.